Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(6):e260124226226.
doi: 10.2174/0118715265276529231214105423.

Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update

Nasim Bakhtiyari  1   2 , Safar Farajnia  2   3 , Samaneh Ghasemali  1   3 , Sahar Farajnia  3 , Ali Pormohammad  4 , Shabnam Saeidvafa  5
Affiliations
Review

Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update

Nasim Bakhtiyari et al. Infect Disord Drug Targets. 2024.

Abstract

Nosocomial infections, also known as healthcare-associated infections, are a significant global concern due to their strong association with high mortality and morbidity in both developed and developing countries. These infections are caused by a variety of pathogens, particularly the ESKAPE group of bacteria, which includes the six pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. These bacteria have demonstrated noteworthy resistance to different antibiotics. Antimicrobial resistance mechanisms can manifest in various forms, including restricting drug uptake, modifying drug targets, inactivating drugs, active drug efflux, and biofilm formation. Accordingly, various strategies have been developed to combat antibiotic-resistant bacteria. These strategies encompass the development of new antibiotics, the utilization of bacteriophages that specifically target these bacteria, antimicrobial combination therapy and the use of peptides or enzymes that target the genomes or essential proteins of resistant bacteria. Among promising approaches to overcome antibiotic resistance, the CRISPR/Cas system stands out and offers many advantages. This system enables precise and efficient editing of genetic material at specific locations in the genome. Functioning as a bacterial "adaptive immune system," the CRISPR/Cas system recognizes, degrades, and remembers foreign DNA sequences through the use of spacer DNA segments that are transcribed into CRISPR RNAs (crRNA). This paper has focused on nosocomial infections, specifically the pathogens involved in hospital infections, the mechanisms underlying bacterial resistance, and the strategies currently employed to address this issue. Special emphasis has been placed on the application of CRISPR/Cas technology for overcoming antimicrobial resistance.

Keywords: Crispr/Cas system; ESKAPE.; antimicrobial peptide; bacteriophage; drug resistance; nosocomial infections.

PubMed Disclaimer

References

    1. Jain N.; Jansone I.; Obidenova T.; Antimicrobial resistance in nosocomial isolates of gram-negative bacteria: Public health implications in the latvian context. Antibiotics 2021,10(7),791 - DOI - PubMed
    1. Zohra T.; Numan M.; Ikram A.; Cracking the challenge of antimicrobial drug resistance with CRISPR/Cas9, Nanotechnology and other strategies in ESKAPE pathogens. Microorganisms 2021,9(5),954 - DOI - PubMed
    1. Suleyman G.; Alangaden G.J.; Nosocomial fungal infections. Infect Dis Clin North Am 2021,35(4),1027-1053 - DOI - PubMed
    1. Greninger A.L.; Zerr D.M.; NGSocomial infections: High-resolution views of hospital-acquired infections through genomic epidemiology. J Pediatric Infect Dis Soc 2021,10(Suppl. 4),S88-S95 - DOI - PubMed
    1. Dadi N.C.T.; Radochová B, Vargová J, Bujdáková H. Impact of healthcare-associated infections connected to medical devices—an update. Microorganisms 2021,9(11),2332 - DOI - PubMed

MeSH terms

Substances